- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Leukemia, Myeloid, Acute in United States
Total 9591 results
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory Acute Myeloid Leukemia | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Persistent DiseaseUnited States
-
Kinex Pharmaceuticals Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
Daiichi Sankyo, Inc.PlexxikonCompletedAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic... and other conditionsUnited States
-
Beat AML, LLCRecruitingPreviously Untreated Acute Myeloid LeukemiaUnited States
-
PersImmune, IncUniversity of California, San DiegoUnknownAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States
-
Polish Adult Leukemia GroupRecruiting
-
University of RochesterCompletedAcute Myeloid LeukemiaUnited States
-
Fred Hutchinson Cancer CenterJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia | Myeloid NeoplasmUnited States
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Genzyme, a Sanofi CompanyCompletedAcute Myeloid LeukemiaUnited States, Singapore
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
Genzyme, a Sanofi CompanyCompletedAcute Myeloid LeukemiaUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaCanada, United States
-
Clavis PharmaSyneos Health; TheradexCompletedAcute Myeloid LeukemiaUnited States, Norway, Germany, France
-
Brian JonasNational Cancer Institute (NCI); AbbVieRecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid LeukemiaUnited States
-
Sudipto MukherjeeActive, not recruitingAcute Myeloid Leukemia | AMLUnited States
-
University of RochesterRecruiting
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingAcute Myeloid LeukemiaUnited States
-
Hoffmann-La RocheCompleted
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | FLT3-mutated Acute Myeloid LeukemiaUnited States
-
AmgenTerminatedRelapsed/Refractory Acute Myeloid Leukemia (AML)United States, Korea, Republic of, Australia, Japan, Germany, Canada
-
National Cancer Institute (NCI)TerminatedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Cancer Institute (NCI)CompletedFollicular Lymphoma | Myeloid Leukemia | Polycythemia Vera | Hodgkin Lymphoma | Myelofibrosis | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Chronic Lymphocytic Leukemia | Secondary Acute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Refractory... and other conditionsUnited States
-
JW PharmaceuticalActive, not recruitingAcute Myeloid LeukemiaUnited States, Korea, Republic of
-
Sunesis PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States
-
BioLineRx, Ltd.Genentech, Inc.TerminatedAcute Myeloid LeukemiaIsrael, Spain, United States, Czechia, Poland, Slovakia
-
Massachusetts General HospitalCelgeneCompleted
-
National Cancer Institute (NCI)TerminatedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute Myeloid Leukemia With 11q23 (MLL)... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedAcute Myeloid LeukemiaUnited States
-
ALX Oncology Inc.Active, not recruitingA Study of Evorpacept (ALX148) With Venetoclax and Azacitidine for Acute Myeloid Leukemia (ASPEN-05)Acute Myeloid Leukemia | AML, AdultUnited States
-
Memorial Sloan Kettering Cancer CenterPfizerWithdrawnAcute Myeloid Leukemia (AML) | Minimal Residual DiseaseUnited States
-
University of Southern CaliforniaSponsor Name PendingWithdrawnAcute Promyelocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteBoston Children's Hospital; Brigham and Women's HospitalCompletedMyelogenous Leukemia, AcuteUnited States
-
Amphivena Therapeutics, Inc.Completed
-
National Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
Northwestern UniversityTerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Virginia Commonwealth UniversityNot yet recruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterHiberCell, Inc.Not yet recruitingAcute Myeloid LeukemiaUnited States
-
Huda SalmanRecruiting
-
OHSU Knight Cancer InstituteOregon Health and Science University; Incyte CorporationRecruitingAcute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior TherapiesUnited States
-
Baylor College of MedicineWilliam Marsh Rice UniversityActive, not recruitingAcute Myeloid LeukemiaUnited States
-
SGX Pharmaceuticals, Inc.TerminatedLeukemia, Myeloid, AcuteUnited States
-
National Cancer Institute (NCI)CompletedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States